Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/183494
Title: Assessment of trimethoprim-sulfamethoxazole susceptibility testing methods for fastidious Haemophilus spp.
Author: Sierra Urueña, Yanik
Tubau, Fe
González Díaz, Aida
Carrera-Salinas, Anna
Moleres, Javier
Bajanca-Lavado, Paula
Garmendia, J.
Domínguez Luzón, Ma. Ángeles (María Ángeles)
Ardanuy Tisaire, María Carmen
Marti Marti, Sara
Keywords: Malalties bacterianes
Antibiòtics
Estabilitat dels medicaments
Bacils
Bacterial diseases
Antibiotics
Drug stability
Bacillus (Bacteria)
Issue Date: 1-Jul-2020
Publisher: European Society of Clinical Microbiology and Infectious Diseases
Abstract: Objectives: To compare the determinants of trimethoprim-sulfamethoxazole resistance with established susceptibility values for fastidious Haemophilus spp., to provide recommendations for optimal trimethoprim-sulfamethoxazole measurement. Methods: We collected 50 strains each of Haemophilus influenzae and Haemophilus parainfluenzae at Bellvitge University Hospital. Trimethoprim-sulfamethoxazole susceptibility was tested by microdilution, E-test and disc diffusion using both Mueller-Hinton fastidious (MH-F) medium and Haemophilus test medium (HTM) following EUCAST and CLSI criteria, respectively. Mutations in folA, folP and additional determinants of resistance were identified in whole-genome-sequenced isolates. Results: Strains presented generally higher rates of trimethoprim-sulfamethoxazole resistance when grown on HTM than on MH-F, independent of the methodology used (average MIC 2.6-fold higher in H. influenzae and 1.2-fold higher in H. parainfluenzae). The main resistance-related determinants were as follows: I95L and F154S/V in folA; 3- and 15-bp insertions and substitutions in folP; acquisition of sul genes; and FolA overproduction potentially linked to mutations in -35 and -10 promoter motifs. Of note, 2 of 19 H. influenzae strains (10.5%) and 9 of 33 H. parainfluenzae strains (27.3%) with mutations and assigned as resistant by microdilution were inaccurately considered susceptible by disc diffusion. This misinterpretation was resolved by raising the clinical resistance breakpoint of the EUCAST guidelines to ≤30 mm. Conclusions: Given the routine use of disc diffusion, a significant number of strains could potentially be miscategorized as susceptible to trimethoprim-sulfamethoxazole despite having resistance-related mutations. A simple modification to the current clinical resistance breakpoint given by the EUCAST guideline for MH-F ensures correct interpretation and correlation with the reference standard method of microdilution.
Note: Versió postprint del document publicat a: https://doi.org/10.1016/j.cmi.2019.11.022
It is part of: Clinical Microbiology and Infection, 2020, vol. 26, num. 7
URI: http://hdl.handle.net/2445/183494
Related resource: https://doi.org/10.1016/j.cmi.2019.11.022
ISSN: 1198-743X
Appears in Collections:Articles publicats en revistes (Patologia i Terapèutica Experimental)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
709403.pdf1.22 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.